Skip to main content

Table 5 Various plant extracts and precursor salts explored to synthesize metallic NPs for their breast cancer applications

From: Biogenic metallic nanoparticles as game-changers in targeted cancer therapy: recent innovations and prospects

Plant used

Metal precursor

Morphology

Cell line

Techniques used

IC50 value

Impact

References

Silver

Tamarindus indica Fruit shell extract

Silver nitrate

Spherical

20–52 nm

MCF7

MTT assay, Dual staining (Ao/EtBr), DCFH-DA staining, Rhodamine 123 staining

20 µg/mL

More nuclear morphological changes significant induction in MMP level compared to control

[216]

Buchanania axillaris leaves

Silver nitrate

Spherical

17–80 nm

MCF7

MTT assay

31 µg/mL

The percent inhibitions of cell growth were found to increase with the increasing concentrations of the nanoparticle

[217]

Cyperus conglomeratus Root Extracts

Silver nitrate

Spherical

70–100 nm

MCF7

MTT assay, Flow cytometry, rtPCR

5 μg/mL

The IC50 concentration of synthesized

Ag NPs after 24 h treatment of MCF-7 cells significantly reduced the mRNA levels of Bcl2, survivin, and YAP genes compared with control untreated MCF-7 cells

[213]

Phoenix dactylifera root extract

Silver nitrate

Spherical

21.65–41.05 nm

MCF-7

MMTT assay, AO/EtBr staining, Flow cytometry

29.6 μg/mL

At S-phase, it was discovered that the cell cycle is arrested, significantly slowing down the rate of cell division

[218]

Conocarpus Lancifolius fruits extract

Silver nitrate

Spherical

5–30 nm

MDA-MB-231

MMTT assay, DCFH-DA staining, Hoechst blue staining, Rhodamine 123

16.8 μg/mL

Observed dose-dependent cytotoxicity against MDA-MB-231 cells through activation of reactive oxygen species (ROS) generation

[219]

Gold

Mentha Longifolia leaf extract

Chloroauric acid

Spherical

36.4 nm

MCF7

Hs578Bst

Hs319.T UACC-3133

MTT assay

MCF7: 274 μg/mL

Hs 578Bst: 279 μg/mL

Hs 319.T: 274 μg/mL

UACC-3133: 201 μg/mL

The biosynthesized nanoparticles had effective antibreast cancer effects against MCF7, Hs 578Bst, Hs 319.T, UACC-3133 cell lines without any cytotoxicity activity against normal cell line i.e., HUVEC

[220]

Tecoma capensis (L.) leaves extract

Gold tetrachloroaurate

Spherical

10–35 nm

MCF7

MTT assay, DPPH assay

T. capensis extract: 23.3 µg/mL

T. capensis Au NPs: 9.6 µg/mL

Both T. capensis Au NPs and T. capensis extract showed significant antioxidant activity with DPPH scavenging percentages of 70.73% for T. capensis Au NPs and 85.62% for T. capensis extract

[221]

Copper oxide

Prunus nepalensis Fruit

Copper sulfate

Crystalline

42.5 nm

MCF7

Human normal cell line: MCF10A

MTT assay, Quantitative RT-PCR

158.5 µg/mL

RT-PCR results showed upregulation in p53, caspase-3, Bax, and caspase-9. Down regulation of mRNA expression recorded in Myc and Ras genes in MCF-7 cells

[222]

Acalypha indica leaf extract

Copper sulfate

Spherical

26–30 nm

MCF7

MTT assay

56.16 µg/mL

Plant-mediated copper oxide NPs showed best anticancer activity

[223]

Syzygium alternifolium stem bark

Copper sulfate pentahydrate

Spherical

5–13 nm

MDA-MB-231

MTT assay

50 µg/mL

From 10, 25, 50, and 100 µg/mL, the concentration of CuONPs increased

[211]

Wrightia tinctoria (Wt) extract

Copper sulfate pentahydrate

Spherical 15–40 nm

MCF-7

MTT assay

119.23 μg/mL

The release of copper ions from the nanoparticles, which bind to the cell's DNA, is the primary cause of Cu NPs harmful effects on cancer cells. As a result, it damages DNA and induces cell death

[224]

Titanium oxide

Gloriosa superba rhizome extract

Titanium hydroxide

Spherical

20–100 nm

MCF7

Normal fibroblast mouse cells: L929

MMTT assay, AO/EtBr and Hoechst staining, DCFH-DA staining, Rhodamine 123, Comet assay

MCF-7: 46.64 µg/mL

L929: 61.81 µg/mL

COMET assay confirmed the DNA destruction in the nanotitania-treated cancer cells.

The biomolecule-coated nanotitania catalysts could be used as potential and novel comp

[210]

Zanthoxylum armatum leaf extract

Titanium tetra butoxide

Spherical

15–50 nm

murine 4T1 mammary carcinoma cells

RPMI-1640 assay, Flow cytometry, TBARS assay, Hemolysis assay

4.11 µg/mL

Z. armatum-derived NPs are as efficient as doxorubicin toward breast carcinoma with no symptoms of cardio toxicity and alteration in the body weight making them safer than doxorubicin

[225]